Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Overview of Hematopoiesis

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Thrombopoietin, the Primary Regulator of Platelet Production: From Mythos to Logos, a Thirty-Year Journey.

Biomolecules·2024

Same author

Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche.

Frontiers in oncology·2022

Same author

JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm.

Stem cells (Dayton, Ohio)·2022

Same author

Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm.

Experimental hematology·2021

Same author

JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment.

Blood cells, molecules & diseases·2021

Same author

D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis.

Frontiers in medicine·2021

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Published on: July 8, 2012

Thrombopoietin in normal and neoplastic stem cell development.

Kenneth Kaushansky¹, Helen M Ranney

¹University of California San Diego Medical Center, San Diego, CA 92103-8811, USA. mal@urmc.rochester.edu

Best Practice & Research. Clinical Haematology

|December 5, 2009

Summary

Thrombopoietin stimulates platelet production and also promotes the self-renewal of hematopoietic stem cells (HSCs) via the c-MPL receptor. This receptor is implicated in myeloproliferative disorders, potentially cooperating with JAK2V(617)F.

More Related Videos

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Pan-myeloid Differentiation of Human Cord Blood Derived CD34⁺ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

Published on: September 28, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Published on: July 8, 2012

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Pan-myeloid Differentiation of Human Cord Blood Derived CD34⁺ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

Published on: September 28, 2022

Area of Science:

Hematology
Stem Cell Biology
Oncology

Background:

Thrombopoietin (TPO) is known to regulate platelet production by acting on megakaryocytic progenitor cells.
The thrombopoietin receptor, c-MPL, is a proto-oncogene product implicated in cell growth and differentiation.
Hematopoietic stem cells (HSCs) are crucial for maintaining blood cell populations throughout life.

Purpose of the Study:

To investigate the role of thrombopoietin and its receptor c-MPL in hematopoietic stem cell self-renewal and expansion.
To explore the potential involvement of the c-MPL receptor in the pathogenesis of human myeloproliferative disorders.

Main Methods:

Studies involved normal murine and human hematopoietic stem cells.
The mechanism of action was investigated through the c-MPL receptor, the product of the myeloproliferative leukaemia (c-MPL) proto-oncogene.

Main Results:

Thrombopoietin was found to stimulate the self-renewal and expansion of normal murine and human hematopoietic stem cells (HSCs).
This stimulation occurs through interaction with the c-MPL receptor.
The c-MPL receptor may play a significant role in the development of myeloproliferative disorders, including essential thrombocythemia, myelofibrosis, and polycythemia vera.

Conclusions:

Thrombopoietin has a dual role, regulating both platelet production and hematopoietic stem cell self-renewal.
The c-MPL receptor is a key mediator of TPO's effects on HSCs.
Dysregulation of c-MPL signaling, potentially in conjunction with mutations like JAK2V(617)F, is implicated in myeloproliferative neoplasms.